Results 111 to 120 of about 25,643 (173)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension

Journal of Rawalpindi Medical College, 2009
Background: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers are being extensively used these days for treatment of mild to moderate hypertension. The selection of either of the two drugs is usually based on physician preference.
Khurram Mansoor
doaj  

Controle de qualidade e estudo da estabilidade do maleato de enalapril [PDF]

, 1993
Rech, Norberto
core  

A renoprotective effect of enalapril in chronictransplantation nephropathy

Терапевтический архив, 2004
Aim. To study safety and efficacy of ACE inhibitor enalapril in chronic transplantation nephropathy (CTN) as well as nephroprotective efficacy of this drug in various clinical variants of CTN. Material and methods.
N A Tomilina, A R Bagdasaryan, E S Stolyarevich, A V Sukhanov, N D Fedorova, I M Ilyinsky, V V Tyrin, A V Frolov   +7 more
doaj  

Long-term clinical experience with enalapril in essential hypertension

, 1983
This study was undertaken to evaluate whether, after long-term enalapril administration tachyphylaxis to the blockade of angiotensin II (Ang II) generation occurs.
Schaller, M. D., Waeber, B., Brunner, H. R., Nussberger, J., Gomez, H. J.   +4 more
core  

Digital pharmacoepidemiology of angiotensin-converting enzyme inhibitors in Russia. [PDF]

Front Pharmacol
Kotlyarov S, Kotlyarova A.
europepmc   +1 more source

Enalapril, Atenolol, Alendronate and DRESS Syndrome - A Case Report. [PDF]

Acta Derm Venereol
Olsson SB, Ehinger M.
europepmc   +1 more source

EFFICIENT VALIDATED METHOD OF HPLC TO DETERMINE ENALAPRIL IN COMBINATED DOSAGE FORM CONTAINING ENALAPRIL AND BISOPROLOL AND IN VITRO DISSOLUTION STUDIES

, 2019
Objective: A rapid and reproducible HPLC method has been developed for the determination of enalapril in experimental combined dosage forms containing bisoprolol and enalapril and for drug dissolution studies.
Logoyda, Liliya
core  

Evaluating plasma carboxylesterase 1 as a protein biomarker for pharmacokinetics and metabolic dysfunction-associated steatotic liver disease. [PDF]

Drug Metab Dispos
Jung SM, Yu H, Wang X, Her L, Zhu HJ.
europepmc   +1 more source

Efficacy and Safety of Sacubitril/Valsartan Versus Enalapril in the Treatment of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Aljubeh R, Almuzainy S, Lemine M, Bseiso M, Kadro K, Metawa A, Qaisar R.   +6 more
europepmc   +1 more source

Adverse event of ACE inhibitors: A descriptive analysis of FAERS data. [PDF]

J Public Health Res
Ahmed NJ.
europepmc   +1 more source